Clinical Trial Update: Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids [Phase 3]

View source ↗

Summary

Phase 3 study comparing enteric-coated mycophenolate sodium with reduced-dose cyclosporine microemulsion to standard-dose cyclosporine microemulsion in elderly …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)
• cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis | Conditions: Denovo Renal Transplantation | Phase 3 | Status: COMPLETED